Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,063,615
  • Shares Outstanding, K 55,330
  • Annual Sales, $ 2,162 M
  • Annual Income, $ 523,370 K
  • 60-Month Beta 1.22
  • Price/Sales 2.84
  • Price/Cash Flow 4.99
  • Price/Book 2.18
  • Price/Earnings ttm 9.82
  • Earnings Per Share ttm 11.29
  • Most Recent Earnings 0.45 on 05/05/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 2.99
  • Number of Estimates 5
  • High Estimate 3.20
  • Low Estimate 2.78
  • Prior Year 3.65
  • Growth Rate Est. (year over year) -18.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.92 +6.48%
on 04/23/20
116.78 -6.16%
on 05/18/20
+7.15 (+6.98%)
since 04/22/20
3-Month
86.88 +26.14%
on 03/23/20
134.27 -18.38%
on 02/24/20
-25.23 (-18.71%)
since 02/21/20
52-Week
86.88 +26.14%
on 03/23/20
154.24 -28.95%
on 12/24/19
-31.33 (-22.23%)
since 05/22/19

Most Recent Stories

More News
Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings

Findings advance research across multiple therapeutic areas for adult and pediatric patients with rare or complex diseases

JAZZ : 109.59 (-1.14%)
Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings

, /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its partners will present seven new abstracts at the virtual American Society of Clinical Oncology (ASCO) Annual...

JAZZ : 109.59 (-1.14%)
Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States

, and , /PRNewswire/ -- Bionical Emas and Jazz Pharmaceuticals (NASDAQ: JAZZ) have entered into an agreement to provide appropriate patients in (U.S.) who have relapsed Small Cell Lung Cancer (SCLC)...

JAZZ : 109.59 (-1.14%)
Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America

, /PRNewswire/ --Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Kim Sablich as executive vice president, general manager of , effective June 1, 2020. In this role, Ms....

JAZZ : 109.59 (-1.14%)
Jazz Pharmaceuticals Announces Participation at Upcoming Virtual Investor Conferences

Jazz Pharmaceuticals plc today announced that the company will webcast its corporate presentations at the following virtual investor conferences:

JAZZ : 109.59 (-1.14%)
Jazz Pharma (JAZZ) Misses on Q1 Earnings & Sales, Cuts View

Jazz Pharmaceuticals (JAZZ) reports lower-than-expected first-quarter 2020 earnings and revenues. It lowers its guidance for 2020. Shares drop.

PFE : 37.50 (+0.64%)
LLY : 151.16 (-0.74%)
BMY : 60.79 (-0.57%)
JAZZ : 109.59 (-1.14%)
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of -31.82% and -0.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

JAZZ : 109.59 (-1.14%)
Jazz: 1Q Earnings Snapshot

DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported a first-quarter loss of $157.8 million, after reporting a profit in the same period a year earlier.

JAZZ : 109.59 (-1.14%)
Jazz Pharmaceuticals Announces First Quarter 2020 Financial Results

, May 5, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2020 and updated 2020 financial guidance.

JAZZ : 109.59 (-1.14%)
Should You Buy Jazz Pharmaceuticals (JAZZ) Ahead of Earnings?

Jazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

JAZZ : 109.59 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade JAZZ with:

Business Summary

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and...

See More

Key Turning Points

2nd Resistance Point 111.77
1st Resistance Point 110.68
Last Price 109.59
1st Support Level 108.81
2nd Support Level 108.03

See More

52-Week High 154.24
Fibonacci 61.8% 128.51
Fibonacci 50% 120.56
Fibonacci 38.2% 112.61
Last Price 109.59
52-Week Low 86.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar